Registration - Consultant

Mint Pharmaceuticals Inc. / Derrick Araneda, Consultant

Registration Information

Client name: Mint Pharmaceuticals Inc.
Lobbyist name: Derrick Araneda, Consultant
Initial registration start date: 2020-03-25
Registration status: Inactive
Registration Number: 940838-366238

Associated Communications

Total Number of Communication Reports: 3

Monthly communication reports in the last 6 months: 0

Version 1 of 1 (2020-03-25 to 2020-07-31)

Lobbying Information

Subject Matters

Government Procurement
Health
International Trade

Subject Matter Details

Policies or Program

Mint Pharmaceuticals is the leading supplier of Hydroxychloroquine to the Canadian market. Mint Pharmaceuticals is reaching out to the Federal government to ask for a letter of support for the government of India so that it can continue to import this critical drug for patients on a humanitarian basis given that the Indian government has just banned the export of 26 API's. Mint pharmaceuticals also plans to discuss issues with reimbursements and shortages in the past years and potential solutions to ensure supply through this pandemic.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Health Canada (HC)
Innovation, Science and Economic Development Canada (ISED)
Intergovernmental Affairs Secretariat (IGA)
Prime Minister's Office (PMO)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
6575 Davand Dr
Mississauga, ON L5T 2M3
Canada

Telephone number: 877-398-9696

Client representative

Jaiveer Singh, CEO

Parent Company Information

Mint Pharmaceuticals Inc. is not a subsidiary of any other parent companies.

Coalition Members Information

Mint Pharmaceuticals Inc. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Mint Pharmaceuticals Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Mint Pharmaceuticals Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Derrick Araneda | No public offices held

Business address:
77 Bloor St W Suite 600
Toronto, ON M5S 2B4
Canada

Telephone number: 416-930-2452

Consultant Firm and Address

Firm: Stosic & Associates

Address:
77 Bloor St W Suite 600
Toronto, ON M5S 2B4
Canada

Telephone number: 416-930-2452

Mint Pharmaceuticals Inc./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Mint Pharmaceuticals Inc./	2020-03-25	2020-07-31

Mint Pharmaceuticals Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Derrick Araneda, Stosic & Associates (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-3 of 3

Mint Pharmaceuticals Inc.
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Director of Policy | Health Canada (HC)
Subject Matter of the communication: Government Procurement, Health, International Trade
Communication date: 2020-04-09
Posted date: 2020-04-13
Communication number: 366238-470020 View associated registration
Mint Pharmaceuticals Inc.
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Director of Policy | Health Canada (HC)
Subject Matter of the communication: Government Procurement, Health, International Trade
Communication date: 2020-04-08
Posted date: 2020-05-15
Communication number: 366238-470018 View associated registration
Mint Pharmaceuticals Inc.
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Sabrina Kim, Issues Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, International Trade
Communication date: 2020-04-07
Posted date: 2020-05-15
Communication number: 366238-470014 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Mint Pharmaceuticals Inc. / Derrick Araneda, Consultant

Registration Information

Associated Communications

Version 1 of 1 (2020-03-25 to 2020-07-31)

Version 1 of 1 (2020-03-25 to 2020-07-31)

Subject Matters

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address